Sign in
4

Changes in Ownership

Petros Pharmaceuticals, Inc. Filed Acc 0001104659-23-006545

Director acquired 2,264 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bradley Greg Director 2023-01-20 Option exercise +2,264 2,264 D
Derivatives
Bradley Greg Director 2023-01-20 Option exercise · Restricted Stock Units −2,264 0 D
Loading xslF345X03/tm234334-2_4seq1.xml…